BrainSee

11/06/2025

We are proud to announce that the 𝗖𝗮𝗹𝗶𝗳𝗼𝗿𝗻𝗶𝗮 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗛𝗲𝗮𝗹𝘁𝗵 𝗙𝗮𝗰𝗶𝗹𝗶𝘁𝗶𝗲𝘀 (𝗖𝗔𝗛𝗙) 𝗵𝗮𝘀 𝘀𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗗𝗮𝗿𝗺𝗶𝘆𝗮𝗻 𝗮𝘀 𝗶𝘁𝘀 𝗣𝗿𝗲𝗳𝗲𝗿𝗿𝗲𝗱 𝗣𝗿𝗼𝘃𝗶𝗱𝗲𝗿 𝗳𝗼𝗿 𝗖𝗼𝗴𝗻𝗶𝘁𝗶𝘃𝗲 𝗛𝗲𝗮𝗹𝘁𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀!

Starting January 2026, we (Darmiyan team) will serve more than 1,300 senior care and skilled nursing facilities across California, serving over 350,000 residents, with our breakthrough, FDA-approved BrainSee™ technology for early brain health assessment, enabling continuous, personalized care and dementia prevention.

Our mission is to transform cognitive power at its source — identity, clarity of thought and decision-making, and the honoring of memories.

Thanks, California Association of Health Facilities, for joining our mission and vision of building a world where brain health is visible, measurable, and improvable before decline begins.

𝗩𝗶𝘀𝗶𝘁 𝘄𝘄𝘄.𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲.𝗮𝗶 𝘁𝗼 𝗹𝗲𝗮𝗿𝗻 𝗺𝗼𝗿𝗲.

Press Release:
https://www.prnewswire.com/news-releases/california-association-of-health-facilities-cahf-selects-darmiyan-as-preferred-provider-for-cognitive-health-solutions-302606885.html

05/29/2025

Darmiyan Receives FDA Approval for Post-Market Surveillance Study of BrainSee, the First-in-Class Clinical Test for Predicting Risk of Progression to Clinical Alzheimer's Disease

/PRNewswire/ -- Darmiyan, Inc., a leading brain health technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the...

05/12/2025

𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲 𝗶𝘀 𝗕𝗿𝗮𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵 𝗠𝗮𝗱𝗲 𝗦𝗶𝗺𝗽𝗹𝗲

BrainSee test provides one simple score, guiding you and your doctor in the next steps.

𝗟𝗼𝘄 𝗦𝗰𝗼𝗿𝗲 (𝘓𝘰𝘸 𝘙𝘪𝘴𝘬): Offers reassurance about your cognitive health.
𝗛𝗶𝗴𝗵 𝗦𝗰𝗼𝗿𝗲 (𝘏𝘪𝘨𝘩 𝘙𝘪𝘴𝘬): Empowers you to take proactive steps to reduce the risk of progression to AD dementia and prevent or postpone it.

Visit 𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲.𝗮𝗶 to Get Started!

04/17/2025

Our BrainSee team was proud to attend the Ellore Grand Opening in Santa Clara, CA.

Here, we met amazing people in the community, and we toured the facility's amenities (pool, penthouse, gym, yoga studio, movie theater, and much more). Ellore, as great event planners as they are, met guests with fantastic food and drinks on every floor of the tour.

We had the pleasure of meeting passionate people in the Aging industry and community. We thank all those who connected with us, and we look forward to working with you all soon.

It was also with great pleasure to see the familiar faces of people we have met from Ivy Park and Oakmont Senior Living, as well as The Alzheimer's Association. It is always a delight to meet with people who have the common goals of improving the longevity and independence of our Seniors.

A big thanks to Ellore for the warm invitation.

03/07/2025

𝗗𝗮𝗿𝗺𝗶𝘆𝗮𝗻 𝗮𝘁 𝘁𝗵𝗲 𝟮𝟬𝟮𝟱 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲:
𝗡𝗲𝘄 𝗬𝗼𝗿𝗸 𝗜𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗲 𝗼𝗳 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆
𝘈𝘯𝘴𝘸𝘦𝘳𝘴 𝘣𝘺 𝘋𝘳. 𝘒𝘢𝘷𝘦𝘩 𝘝𝘦𝘫𝘥𝘢𝘯𝘪- 𝘊𝘩𝘪𝘦𝘧 𝘔𝘦𝘥𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘛𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘖𝘧𝘧𝘪𝘤𝘦𝘳

𝗜𝗻𝘁𝗿𝗼: 𝗘𝗹𝗲𝘃𝗮𝘁𝗼𝗿 𝗣𝗶𝘁𝗰𝗵:
𝗔: Early risk assessment of Alzheimer’s Disease at the early stages called Mild Cognitive Impairment (MCI). We’ve built a medical software that combines brain structure and function with brain MRI and cognitive assessments that doctors do in the office. 𝗜𝘁 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗲𝘀 𝗮 𝗽𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝘀𝗰𝗼𝗿𝗲 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝟬 𝗮𝗻𝗱 𝟭𝟬𝟬 𝘁𝗵𝗮𝘁 𝗲𝘀𝘁𝗶𝗺𝗮𝘁𝗲𝘀 𝘁𝗵𝗲 𝗹𝗶𝗸𝗲𝗹𝗶𝗵𝗼𝗼𝗱 𝗼𝗳 𝗽𝗿𝗼𝗴𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗳𝗿𝗼𝗺 𝗠𝗖𝗜 𝘁𝗼 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿’𝘀 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮 𝗶𝗻 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝟱 𝘆𝗲𝗮𝗿𝘀.
Visit BrainSee or www.𝘉𝘳𝘢𝘪𝘯𝘚𝘦𝘦.𝘢𝘪 to learn more.

𝗤: 𝗛𝗼𝘄 𝗱𝗶𝗱 𝘆𝗼𝘂 𝗯𝘂𝗶𝗹𝗱 𝗮 𝘁𝗲𝗮𝗺 𝘁𝗼 𝗵𝗲𝗹𝗽 𝘆𝗼𝘂 𝗮𝗱𝘃𝗮𝗻𝗰𝗲?
𝗔: Early on, when you are building your core team because you are a small group of people, 𝙚𝙫𝙚𝙧𝙮𝙗𝙤𝙙𝙮 𝙝𝙖𝙨 𝙩𝙤 𝙬𝙚𝙖𝙧 𝙢𝙪𝙡𝙩𝙞𝙥𝙡𝙚 𝙝𝙖𝙩𝙨. Essentially, because there is too much work to do in a small startup and you’re a small team, so you’ll have to 𝙛𝙞𝙣𝙙 𝙢𝙪𝙡𝙩𝙞-𝙩𝙖𝙡𝙚𝙣𝙩𝙚𝙙 𝙥𝙚𝙤𝙥𝙡𝙚 𝙖𝙣𝙙 𝙢𝙪𝙡𝙩𝙞-𝙨𝙠𝙞𝙡𝙡𝙚𝙙 𝙥𝙚𝙤𝙥𝙡𝙚, which fortunately in academic environments there are a lot of them around us. Also, there are some skills that we don’t have naturally as academicians or clinicians in finance or in other areas, then you could 𝙖𝙩𝙩𝙧𝙖𝙘𝙩 𝙚𝙭𝙥𝙚𝙧𝙩 𝙩𝙖𝙡𝙚𝙣𝙩.

When you are founding your core founding team, it's very helpful if 𝙩𝙝𝙚 𝙘𝙤𝙧𝙚 𝙩𝙚𝙖𝙢 𝙝𝙖𝙨 𝙖 𝙫𝙚𝙧𝙮 𝙨𝙩𝙧𝙤𝙣𝙜 𝙛𝙧𝙞𝙚𝙣𝙙𝙨𝙝𝙞𝙥 𝙤𝙧 𝙖 𝙨𝙩𝙧𝙤𝙣𝙜 𝙧𝙚𝙡𝙖𝙩𝙞𝙤𝙣𝙨𝙝𝙞𝙥 𝙤𝙪𝙩𝙨𝙞𝙙𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙬𝙤𝙧𝙠. Initially, in the early days, there are a lot of challenges, you'll have a lot of disagreements, and it's important to be able to survive through them. 𝙏𝙝𝙚 𝙗𝙤𝙣𝙙 𝙩𝙝𝙖𝙩 𝙮𝙤𝙪 𝙝𝙖𝙫𝙚 𝙤𝙪𝙩𝙨𝙞𝙙𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙬𝙤𝙧𝙠 𝙚𝙣𝙫𝙞𝙧𝙤𝙣𝙢𝙚𝙣𝙩 𝙝𝙚𝙡𝙥𝙨 𝙖 𝙡𝙤𝙩 𝙬𝙞𝙩𝙝 𝙗𝙚𝙞𝙣𝙜 𝙖𝙗𝙡𝙚 𝙩𝙤 𝙜𝙚𝙩 𝙩𝙝𝙧𝙤𝙪𝙜𝙝 𝙩𝙝𝙚 𝙘𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨.

𝗤: 𝗪𝗵𝗮𝘁 𝗶𝘀 𝘁𝗵𝗲 𝗯𝗲𝘀𝘁 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝘆 𝘁𝗼 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗲 𝗮 𝘀𝘁𝗮𝗿𝘁𝘂𝗽?
𝗔: Start with market research and ask people around, see 𝙬𝙝𝙖𝙩 𝙞𝙨 𝙩𝙝𝙚𝙞𝙧 𝙥𝙖𝙞𝙣 𝙥𝙤𝙞𝙣𝙩. Don’t try to look for a customer for a product. First find what people want and then 𝙨𝙚𝙚 𝙞𝙛 𝙮𝙤𝙪𝙧 𝙩𝙚𝙘𝙝𝙣𝙤𝙡𝙤𝙜𝙮 𝙤𝙧 𝙬𝙝𝙖𝙩 𝙮𝙤𝙪 𝙖𝙧𝙚 𝙙𝙚𝙫𝙚𝙡𝙤𝙥𝙞𝙣𝙜 𝙘𝙖𝙣 𝙖𝙣𝙨𝙬𝙚𝙧 𝙩𝙝𝙚𝙞𝙧 𝙥𝙖𝙞𝙣 𝙥𝙤𝙞𝙣𝙩.

Streaming live: https://lnkd.in/gQ3EWWwQ

03/06/2025

𝗧𝗵𝗲 BrainSee 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗮𝗿𝗲 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲
𝗣𝗿𝗲𝘃𝗲𝗻𝘁, 𝗣𝗼𝘀𝘁𝗽𝗼𝗻𝗲 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮
𝘈𝘭𝘻𝘩𝘦𝘪𝘮𝘦𝘳'𝘴 𝘈𝘸𝘢𝘳𝘦𝘯𝘦𝘴𝘴 𝘉𝘦𝘨𝘪𝘯𝘴 𝘸𝘪𝘵𝘩 𝘈𝘤𝘤𝘶𝘳𝘢𝘵𝘦 𝘛𝘦𝘴𝘵𝘪𝘯𝘨 𝘢𝘵 𝘉𝘳𝘢𝘪𝘯𝘚𝘦𝘦.𝘢𝘪
𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗡𝗼𝘄!

BrainSee is an innovative platform offering the first fully non-invasive, FDA-approved test for assessing the likelihood of progression to Alzheimer’s disease (AD) dementia over the next 5 years.

Our dedicated doctors are committed to helping you move from 𝘩𝘪𝘨𝘩-𝘳𝘪𝘴𝘬 to 𝘭𝘰𝘸-𝘳𝘪𝘴𝘬 and maintain that 𝘭𝘰𝘸-𝘳𝘪𝘴𝘬 status.

Visit 𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲.𝗮𝗶 to get started and book your appointment today!

02/19/2025

𝗕𝗮𝗶𝗻𝗦𝗲𝗲'𝘀 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿'𝘀 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗣𝗿𝗼𝗴𝗿𝗮𝗺
𝘈𝘭𝘻𝘩𝘦𝘪𝘮𝘦𝘳'𝘴 𝘈𝘸𝘢𝘳𝘦𝘯𝘦𝘴𝘴 𝘉𝘦𝘨𝘪𝘯𝘴 𝘸𝘪𝘵𝘩 𝘈𝘤𝘤𝘶𝘳𝘢𝘵𝘦 𝘛𝘦𝘴𝘵𝘪𝘯𝘨 𝘢𝘵 𝘉𝘳𝘢𝘪𝘯𝘚𝘦𝘦.𝘢𝘪
𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗡𝗼𝘄!

BrainSee is the first fully non-invasive, FDA-approved test for assessing the likelihood of progression to Alzheimer’s disease (AD) dementia over the next 5 years.
BrainSee test provides one simple score, guiding the next steps for you and your doctor.
𝗟𝗼𝘄 𝗦𝗰𝗼𝗿𝗲 (𝘓𝘰𝘸 𝘙𝘪𝘴𝘬): Offers reassurance about your cognitive health.
𝗛𝗶𝗴𝗵 𝗦𝗰𝗼𝗿𝗲 (𝘏𝘪𝘨𝘩 𝘙𝘪𝘴𝘬): Empowers you to take proactive steps to reduce the risk of progression to AD dementia and prevent or postpone it.

Our dedicated doctors are committed to helping you move from 𝘩𝘪𝘨𝘩-𝘳𝘪𝘴𝘬 to 𝘭𝘰𝘸-𝘳𝘪𝘴𝘬 and maintain that 𝘭𝘰𝘸-𝘳𝘪𝘴𝘬 status.

Visit 𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲.𝗮𝗶 to get started and book your appointment today!

11/20/2024

With the combined efforts of BrainSee and DarmiSpace, we can redefine brain wellness.

11/20/2024

𝗗𝗮𝗿𝗺𝗶𝘆𝗮𝗻 𝗟𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗗𝗮𝗿𝗺𝗶𝗦𝗽𝗮𝗰𝗲 𝗧𝗼𝗱𝗮𝘆!

DarmiSpace is a first-in-class, comprehensive & holistic brain wellness platform that offers:
• Multi-dimensional brain wellness evaluation
• Personalized analysis/feedback
• Actionable guidance
• An option to engage family, doctor, mentor
• Advanced search of vetted information

Visit 𝗗𝗮𝗿𝗺𝗶𝗦𝗽𝗮𝗰𝗲.𝗰𝗼𝗺 to Learn more!

11/19/2024

𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲 𝗶𝘀 𝗻𝗼𝘄 𝗼𝗻 𝗜𝗻𝘀𝘁𝗮𝗴𝗿𝗮𝗺!

Follow us to get new updates, watch us collaborate with inspiring community advocates, and see how BrainSee can benefit you or a loved one.

For more information about BrainSee, Visit BrainSee.ai.

11/05/2024

𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲 𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝘀 𝘁𝗵𝗲 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿'𝘀 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝘁𝗵𝗲 𝗪𝗮𝗹𝗸 𝘁𝗼 𝗘𝗻𝗱 𝗔𝗹𝘇𝗵𝗲𝗶𝗺𝗲𝗿'𝘀 𝗘𝘃𝗲𝗻𝘁, 𝗦𝗮𝗻 𝗝𝗼𝘀𝗲!

We are proud to announce that our team 𝗲𝘅𝗰𝗲𝗲𝗱𝗲𝗱 our fundraising goal for the Walk to End Alzheimer's fundraiser. 🙌

Thank you to all who donated to the cause. Your generosity enabled us to help support the Alzheimer's Association in its mission.

𝗙𝘂𝗿 𝗙𝗿𝗶𝗲𝗻𝗱𝘀 𝘁𝗼 𝘁𝗵𝗲 𝗥𝗲𝘀𝗰𝘂𝗲
Our team was proud to bring our fur friends along to support the cause. These rescues are Olive(dachshund-chihuahua), Snoopy (schnauzer-poodle), and Tobias(Husky) all walked in a pack to show us that together we are strong, and together, we walked to end Alzheimer's.

𝗪𝗵𝘆 𝗪𝗲 𝗪𝗮𝗹𝗸
Many of our team members have had a loved one affected by Alzheimer's/Dementia. It is through that we seek to take action, make a positive impact, and redefine life with Alzheimer's by preventing or postponing it.

𝗧𝗵𝗲 𝗣𝗿𝗼𝗺𝗶𝘀𝗲 𝗚𝗮𝗿𝗱𝗲𝗻
The Promise Garden was a very emotional part of the event. Here, we were able to commemorate our loved ones and show our support for the cause.
🔵 𝘉𝘭𝘶𝘦: I have Alzheimer's/ Dementia
🟡 𝘠𝘦𝘭𝘭𝘰𝘸: I am supporting or caring for someone with Alzheimer’s/dementia
🟣 𝘗𝘶𝘳𝘱𝘭𝘦: I have lost someone to Alzheimer’s/dementia
🟠 𝘖𝘳𝘢𝘯𝘨𝘦: I support the cause and the Alzheimer’s Association's vision of a world without Alzheimer’s

Thank you to our Founders & Team for supporting this cause!

10/29/2024

𝗧𝗵𝗲 BrainSee 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗮𝗿𝗲 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲
𝗣𝗿𝗲𝗱𝗶𝗰𝘁, 𝗣𝗿𝗲𝘃𝗲𝗻𝘁, 𝗣𝗼𝘀𝘁𝗽𝗼𝗻𝗲 𝗗𝗲𝗺𝗲𝗻𝘁𝗶𝗮
𝘈𝘭𝘻𝘩𝘦𝘪𝘮𝘦𝘳'𝘴 𝘈𝘸𝘢𝘳𝘦𝘯𝘦𝘴𝘴 𝘉𝘦𝘨𝘪𝘯𝘴 𝘸𝘪𝘵𝘩 𝘈𝘤𝘤𝘶𝘳𝘢𝘵𝘦 𝘛𝘦𝘴𝘵𝘪𝘯𝘨 𝘢𝘵 𝘉𝘳𝘢𝘪𝘯𝘚𝘦𝘦.𝘢𝘪
𝗔𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 𝗡𝗼𝘄!

BrainSee is an innovative platform offering the first fully non-invasive, FDA-approved test for assessing the likelihood of progression to Alzheimer’s disease (AD) dementia over the next five years.

BrainSee test provides one simple score, guiding the next steps for you and your doctor.
𝗟𝗼𝘄 𝗦𝗰𝗼𝗿𝗲 (𝘓𝘰𝘸 𝘙𝘪𝘴𝘬): Offers reassurance about your cognitive health.
𝗛𝗶𝗴𝗵 𝗦𝗰𝗼𝗿𝗲 (𝘏𝘪𝘨𝘩 𝘙𝘪𝘴𝘬): Empowers you to take proactive steps to reduce the risk of progression to AD dementia and prevent or postpone it.

Our dedicated doctors are committed to helping you move from 𝘩𝘪𝘨𝘩-𝘳𝘪𝘴𝘬 to 𝘭𝘰𝘸-𝘳𝘪𝘴𝘬 and maintain that 𝘭𝘰𝘸-𝘳𝘪𝘴𝘬 status.

Visit 𝗕𝗿𝗮𝗶𝗻𝗦𝗲𝗲.𝗮𝗶 to get started and book your appointment today!